July 30, 2016 7:13 AM ET


Company Overview of Corbus Pharmaceuticals Holdings, Inc.

Executive Profile

Yuval Cohen Ph.D.

Chief Executive Officer and Director, Corbus Pharmaceuticals Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Yuval Cohen, Ph.D., has been the Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. since April 11, 2014. Dr. Cohen served as Senior Vice President at Celsus Therapeutics Plc (formerly, Morria Biopharmaceuticals Plc) from February 2013 to December 10, 2013 and served as its President since January 12, 2005. Dr. Cohen served as the Managing Director of Celsus Therapeutics Plc. Dr. Cohen has been the driving force behind transforming MFAID technology ...

Corporate Headquarters

100 River Ridge Drive
Norwood, Massachusetts 02062

United States

Phone: 617-963-0100
Fax: --

Board Members Memberships

Chief Executive Officer and Director
Chief Executive Officer and Director


University of Cape Town
Universite Rene Descartes Paris V

Other Affiliations

Annual Compensation

Total Annual Compensation$240,000

Stocks Options

Exercisable Options$490,679
Unexercisable Options$682,522
Total Number of Options$1,453,201

Total Compensation

Total Annual Cash Compensation$240,000
Total Short Term Compensation$240,000
Total Calculated Compensation$240,000

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Corbus Pharmaceuticals Holdings, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.